User profiles for William M. Flanagan

William Flanagan

Statistics Canada
Verified email at statcan.gc.ca
Cited by 915

Small-molecule inhibition of TNF-α

MM He, AS Smith, JD Oslob, WM Flanagan… - Science, 2005 - science.org
We have identified a small-molecule inhibitor of tumor necrosis factor α (TNF-α) that promotes
subunit disassembly of this trimeric cytokine family member. The compound inhibits TNF-α …

Trends in risk factors for cardiovascular disease in Canada: temporal, socio-demographic and geographic factors

…, TF Mitiku, LW Svenson, W Putnam, WM Flanagan… - Cmaj, 2009 - Can Med Assoc
Background: Temporal trends in risk factors for cardiovascular disease and the impact of
socio-economic status on these risk factors remain unclear. Methods: Using data from the …

[HTML][HTML] Validation of population-based disease simulation models: a review of concepts and methods

…, WM Flanagan, J Oderkirk, M Abrahamowicz… - BMC public health, 2010 - Springer
Background Computer simulation models are used increasingly to support public health
research and policy, but questions about their quality persist. The purpose of this article is to …

Cost-effectiveness of lung cancer screening in Canada

JR Goffin, WM Flanagan, AB Miller… - JAMA …, 2015 - jamanetwork.com
Importance The US National Lung Screening Trial supports screening for lung cancer among
smokers using low-dose computed tomographic (LDCT) scans. The cost-effectiveness of …

Discovery of a potent and selective aurora kinase inhibitor

…, S Baskaran, M Bui, RA Elling, WM Flanagan… - Bioorganic & medicinal …, 2008 - Elsevier
This communication describes the discovery of a novel series of Aurora kinase inhibitors. Key
SAR and critical binding elements are discussed. Some of the more advanced analogues …

Biennial lung cancer screening in Canada with smoking cessation—outcomes and cost-effectiveness

JR Goffin, WM Flanagan, AB Miller, NR Fitzgerald… - Lung Cancer, 2016 - Elsevier
Background Guidelines recommend low-dose CT (LDCT) screening to detect lung cancer
among eligible at-risk individuals. We used the OncoSim model (formerly Cancer Risk …

[HTML][HTML] The Population Health Model (POHEM): an overview of rationale, methods and applications

DA Hennessy, WM Flanagan, P Tanuseputro… - Population health …, 2015 - Springer
The POpulation HEalth Model (POHEM) is a health microsimulation model that was developed
at Statistics Canada in the early 1990s. POHEM draws together rich multivariate data …

Risk of work loss due to illness or disability in patients with osteoarthritis: a population-based cohort study

B Sharif, R Garner, C Sanmartin, WM Flanagan… - …, 2016 - academic.oup.com
Objectives. To estimate the risk of work loss due to illness or disability in a cohort of employed
persons with OA compared with matched non-OA individuals. Methods. We performed a …

Clinical impact and cost-effectiveness of integrating smoking cessation into lung cancer screening: a microsimulation model

WK Evans, CL Gauvreau, WM Flanagan… - … Open Access Journal, 2020 - cmajopen.ca
Background: Low-dose computed tomography (CT) screening can reduce lung cancer mortality
in people at high risk; adding a smoking cessation intervention to screening could further …

Trends in physician‐diagnosed osteoarthritis incidence in an administrative database in British Columbia, Canada, 1996–1997 through 2003–2004

…, EC Sayre, J Cibere, WM Flanagan… - Arthritis Care & …, 2008 - Wiley Online Library
Objective Prevalence of osteoarthritis (OA) is expected to increase due to population aging.
However, there is little information on the trends in the incidence of OA over time. The …